Rising Need of Organ Transplantation to Boost the 3D Bioprinting Market Growth


3D Bioprinting Market, By Technology (Syringe/extrusion Bioprinting, Inkjet Bioprinting, Magnetic Levitation Bioprinting, Laser-assisted Bioprinting, Other Technologies), By Component (3D Bioprinters, Biomaterials, Scaffolds), By Application (Drug Testing and Development, Regenerative Medicine, Food Testing, Research, Other Applications), By Geography (North America Europe, Asia-Pacific, Rest of the World) - Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030

The global 5G Chipset Market is estimated to be valued at US$ XX million in XXX and is expected to exhibit a CAGR of XX% over the forecast period, as highlighted in a new report published by Coherent Market Insights.

3D Bioprinting or bioprinting is a kind of additive production that utilizes tissues and biomaterials rather than traditional metals and plastics to make 3D constructs that are useful 3D tissues. These biomaterials are known as bioinks, and they perform the combination of the cells. Bioprinting can be used in a variety of parts however are not restricted to regenerative drugs, medicine discovery and innovation, and 3D cell culture.

The 3D Bioprinting Market was valued at US$ 875.33 Mn in 2021 and is forecast to reach a value of US$ 4,815.02 Mn by 2030 at a CAGR of 21% between 2022 and 2030.

Market Key Drivers:

Rising need of organ transplantation is expected to augment the growth of global 3D printing market. For instance, as per UNOS Data, around 129,681 organ transplants were performed.

Increasing respiratory diseases is projected to propel the growth of global 3D printing market. For instance, as per CDC, around 37 million people were affected with respiratory diseases.

Competitive Landscape:

Key players involved in the global 3D printing market are RegenHU SA,Organovo Holdings Inc., 3D Systems Corporation, ARCAM AB (GE Company), Aspect Biosystems Ltd., EnvisionTEC GmbH, Cyfuse Biomedical KK, GeSIM GmbH, 3D Bioprinting Solutions, Cellink AB, REGEMAT 3D, and Stratasys Ltd.

Covid-19 Impact Analysis:

The Covid-19 outbreak had adversely affected the growth of global 3D printing market. Hence, as the rising prevalence of Covid-19, several 3D Bioprinting companies are responding to the global crises by providing their respective skills to comfort the burden on the supply chain and regulatory. As the incidences of COVID-19 are rising day by day, there has been a lack of materials for the clinical experts and for the general public.

Key Takeaways:

The global 3D printing market is anticipated to exhibit a CAGR of XX % during the forecast period owing to rising adoptions, collaborations and launches. For instance, in November 2019, BASF GmbH adopted Sculpteo, a 3D printing service supplier.

Among regions, North America, Europe and Asia Pacific are expected to witness robust growth in global 3D printing market due to rising adoption of IT in hospital sector, rising cases of Covid-19 and increasing regulatory initiatives. For instance, according to the Worldometer Report 2021, over 23,369,732 active cases of COVID-19 were confirmed in the U.S. till January 13, 2021.

Comments

Popular posts from this blog

Recent Advancement in Synthesis and Process Development Of Polyether Polyols

Food Additives have been Playing Significant Role in Enhancing Quality and Taste of the Food

Linear Motion System Control Movements with Various Variables and Complication